Table of Content

Open Access iconOpen Access

RETRACTION

Retraction: Liquiritigenin Inhibits Colorectal Cancer Proliferation, Invasion, and Epithelial-to-Mesenchymal Transition by Decreasing Expression of Runt-Related Transcription Factor 2

Oncology Research Editorial Office

Oncology Research 2024, 32(8), 1373-1373. https://doi.org/10.32604/or.2024.055031

This article is a retraction of:

Liquiritigenin Inhibits Colorectal Cancer Proliferation, Invasion, and Epithelial-to-Mesenchymal Transition by Decreasing Expression of Runt-Related Transcription Factor 2
Read original article

Abstract

This article has no abstract.

Cite This Article

APA Style
Oncology Research Editorial Office (2024). Retraction: liquiritigenin inhibits colorectal cancer proliferation, invasion, and epithelial-to-mesenchymal transition by decreasing expression of runt-related transcription factor 2. Oncology Research, 32(8), 1373-1373. https://doi.org/10.32604/or.2024.055031
Vancouver Style
Oncology Research Editorial Office. Retraction: liquiritigenin inhibits colorectal cancer proliferation, invasion, and epithelial-to-mesenchymal transition by decreasing expression of runt-related transcription factor 2. Oncol Res. 2024;32(8):1373-1373 https://doi.org/10.32604/or.2024.055031
IEEE Style
Oncology Research Editorial Office, "Retraction: Liquiritigenin Inhibits Colorectal Cancer Proliferation, Invasion, and Epithelial-to-Mesenchymal Transition by Decreasing Expression of Runt-Related Transcription Factor 2," Oncol. Res., vol. 32, no. 8, pp. 1373-1373. 2024. https://doi.org/10.32604/or.2024.055031



cc This work is licensed under a Creative Commons Attribution 4.0 International License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
  • 172

    View

  • 34

    Download

  • 0

    Like

Share Link